---
layout: post
title: "Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation Decisions, Suspension/Revocation of Certificates, or Patient and Physician Notification Orders; Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:58:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-04405
original_published: 2022-03-02 00:00:00 +0000
significance: 8.00
---

# Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation Decisions, Suspension/Revocation of Certificates, or Patient and Physician Notification Orders; Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 02, 2022 00:00 UTC
**Document Number:** 2022-04405

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Appeal Options Available to Mammography Facilities Concerning Adverse Accreditation Decisions, Suspension/Revocation of Certificates, or Patient and Physician Notification Orders." This guidance document describes the processes available to mammography facilities to request additional review of an adverse appeals decision on a facility's accreditation, and/or a suspension or revocation of certificate, and/or a patient and physician notification order. This guidance supersedes section 4.5 of the Center for Devices and Radiological Health (CDRH) Appeals Processes guidance document dated July 2, 2019.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/02/2022-04405/appeal-options-available-to-mammography-facilities-concerning-adverse-accreditation-decisions)
- API: https://www.federalregister.gov/api/v1/documents/2022-04405

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
